Literature DB >> 7890418

Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen.

S Sethi1, S L Hill, T F Murphy.   

Abstract

Moraxella (Branhamella) catarrhalis is a common cause of lower respiratory tract infections in adults and of otitis media in children. Little is known about the human immune response to this bacterium. In this study, immunoblot assays were performed to detect serum immunoglobulin G antibodies directed at purified outer membrane of M. catarrhalis. Twelve serum samples, two each from six patients with bronchiectasis who were persistently colonized with this organism, were tested with their homologous M. catarrhalis sputum isolates. In all the sera, the most prominent and consistent antibody response was to a minor 84-kDa outer membrane protein, OMP B1. Immunoblot adsorption assays show that these antibodies recognize surface exposed epitopes on OMP B1. Further analysis of human serum antibodies eluted from the surface of intact bacterial cells shows that these surface-exposed epitopes on OMP B1 are heterogeneous among strains of M. catarrhalis. OMP B1 is therefore an important OMP antigen on the surface of M. catarrhalis for the human immune response to infection by this bacterium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890418      PMCID: PMC173183          DOI: 10.1128/iai.63.4.1516-1520.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis.

Authors:  A Buret; A W Cripps
Journal:  Am Rev Respir Dis       Date:  1993-09

2.  Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.

Authors:  R E Hancock; E C Mouat; D P Speert
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

Review 3.  The surface of Branhamella catarrhalis: a systematic approach to the surface antigens of an emerging pathogen.

Authors:  T F Murphy
Journal:  Pediatr Infect Dis J       Date:  1989-01       Impact factor: 2.129

4.  Legionella pneumophila surface antigens cloned and expressed in Escherichia coli are translocated to the host cell surface and interact with specific anti-Legionella antibodies.

Authors:  N C Engleberg; E Pearlman; B I Eisenstein
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

5.  Immunoblot method for identifying surface components, determining their cross-reactivity, and investigating cell topology: results with Haemophilus influenzae type b.

Authors:  M R Loeb
Journal:  Anal Biochem       Date:  1984-11-15       Impact factor: 3.365

6.  Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis.

Authors:  L C Bartos; T F Murphy
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

7.  Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  P B Fernandes; C Kim; K R Cundy; N N Haung
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis.

Authors:  J S Lam; L M Mutharia; R E Hancock; N Høiby; K Lam; L Baek; J W Costerton
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

Review 9.  Pneumonia due to Moraxella (Branhamella) catarrhalis.

Authors:  P W Wright; R J Wallace
Journal:  Semin Respir Infect       Date:  1989-03

10.  Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease.

Authors:  B Nicotra; M Rivera; J I Luman; R J Wallace
Journal:  Arch Intern Med       Date:  1986-05
View more
  14 in total

1.  Immune response to Haemophilus parainfluenzae in patients with chronic obstructive lung disease.

Authors:  J L Mitchell; S L Hill
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis.

Authors:  S Sethi; J M Surface; T F Murphy
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 5.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis.

Authors:  C Aebi; L D Cope; J L Latimer; S E Thomas; C A Slaughter; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin.

Authors:  A A Campagnari; T F Ducey; C A Rebmann
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis.

Authors:  R H Yu; R A Bonnah; S Ainsworth; A B Schryvers
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

9.  The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.

Authors:  L E Myers; Y P Yang; R P Du; Q Wang; R E Harkness; A B Schryvers; M H Klein; S M Loosmore
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 10.  Vaccine targets against Moraxella catarrhalis.

Authors:  Dabin Ren; Michael E Pichichero
Journal:  Expert Opin Ther Targets       Date:  2015-08-26       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.